If you have been reading about incretin receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-02-18. Numbers and descriptions here follow the published literature rather than marketing material.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual incretin receptor agonist |
| Amino acid count | 39 residues | Includes non-natural residues |
| Approximate mass | 4.8 kDa | Reported values vary slightly by source |
| Fatty acid component | C20 diacid | Supports albumin binding |
| First US approval | 2022 | Glycemic indication, weight management followed |
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Ein Selenmangel führt zu einem Mangel an Thyroxin-5′-Deiodase, wodurch nur noch ein Teil des verfügbaren T4 deiodiert werden kann. Da T3 im Stoffwechsel wesentlich wirksamer ist, resultiert aus einem T3-Mangel eine Schilddrüsenunterfunktion (Hypothyreose). Thioredoxinreduktase (TrxR), die das für das Zellwachstum wichtige Thioredoxin und zahlreiche weitere nieder- und hochmolekulare Substrate reduziert. Iodthyronin-5′-Deiodinasen (Schilddrüsenhormondeiodinasen; ID-I, ID-II, ID-III) katalysieren die Synthese von Schilddrüsenhormonen. Selenoproteine, die im Zentrum die modifizierte Aminosäure Selenocystein tragen, darunter Selenprotein H, I, K, M, N, O und P dienen als Transportprotein für Selen zwischen Körperzellen; R, die Methioninsulfoxid-Reduktase sowie S, T, V und W kommen in der Muskulatur vor. Selenophosphatsynthetase 2 katalysiert die Synthese von Monoselenophosphat, einem Vorläufer von Selenocystein. Selen wirkt in höheren Konzentrationen stark toxisch, wobei die Spanne zwischen Konzentrationen, die Mangelerscheinungen hervorrufen, und toxischen Konzentrationen sehr gering ist. Zudem ist die Toxizität von Selen abhängig von der chemischen Bindungsform.
=== Selenanreicherung in der Nahrungskette === Algen und Mikroorganismen in aquatischer Umgebung können Selen aus dem Wasser aufnehmen und um das Millionenfache der wässrigen Konzentration anreichern. Selen wird oft in Form von Seleniten und Selenaten über die Wurzeln von Pflanzen aufgenommen und gelangen auf diese Weise in die Nahrungskette. Pflanzen bauen Selen je nach Bodengehalt anstelle des Schwefels unspezifisch in Aminosäuren ein, besonders in Selenomethionin und in geringem Umfang Selenocystein beziehungsweise in dessen Derivate wie Methylselenocystein. Nur die sogenannten „Selensammlerpflanzen“ (Selenakkumulator-Pflanzen, zum Beispiel Paradiesnuss), die in selenreichen Gebieten mit aridem Klima vorkommen, speichern Selen darüber hinaus als organisch gebundenes, wasserlösliches Selen oder Selensalze. Der Umfang der Aufnahme hängt ab von der Bioverfügbarkeit des Selens. Hohe organische Anteile adsorbieren Selen und reduzieren es, so dass es immobilisiert ist und durch Pflanzen nicht aufgenommen werden kann. Als selenarme Böden gelten Böden mit Konzentrationen unter 0,1 Parts per million (ppm), bei Selenkonzentrationen über 0,5 ppm gelten Böden als selenreich.
=== Selenaufnahme === Basierend auf der Sättigung des Selenoproteins P mit Selen wurde die empfohlene Tagesdosis in Deutschland, Österreich und der Schweiz auf 70 μg für einen Mann, 60 μg für eine Frau und 75 μg pro Tag für stillende Frauen festgelegt. Der Bedarf bei Kindern und Jugendlichen wird altersabhängig geringer geschätzt. Der Wissenschaftliche Ausschuss für Lebensmittel der Europäischen Kommission legte 1993 einen Referenzwert von 55 μg Selen pro Tag für Erwachsene fest. Einer Bewertung des Ausschusses zufolge soll die tägliche Gesamtaufnahme 300 μg pro Tag nicht übersteigen. Das deutsche Bundesinstitut für Risikobewertung (BfR) empfiehlt für Nahrungsergänzungsmittel die Tagesdosis auf 45 μg zu beschränken. Das US-amerikanische National Institutes of Health (NIH) empfiehlt als normale Dosis für Erwachsene 55 µg Selen pro Tag, und als obere Toleranzgrenze, bei der noch keine negativen Auswirkungen auf die Gesundheit zu erwarten sind, 400 μg pro Tag.
Sources: de.wikipedia.org
=== Medizinische Aspekte === Die Europäische Behörde für Lebensmittelsicherheit (EFSA) befand ausreichend wissenschaftlich belegt, dass Selen zu einer normalen Spermatogenese, zur Erhaltung von Haaren und Nägeln, zur normalen Funktion des Immunsystems und zum Schutz der Zellen vor oxidativem Stress sowie zur normalen Schilddrüsenfunktion beiträgt. Eine Veröffentlichung der Zeitschrift Pharmainformation vom Juni 2005 behandelte die zusätzliche Selengabe mit Blick auf postulierte Nützlichkeit bei verschiedenen Krankheiten: Keine der verfügbaren Studien erbrachte Hinweise für einen Nutzen von Selen in irgendeinem Zusammenhang. Zwar scheint eine positive Beeinflussung verschiedener Krebsarten möglich, andererseits die Begünstigung anderer Karzinome nicht unwahrscheinlich. Ein solcher Zusammenhang wird für Herz-Kreislauf-Erkrankungen diskutiert. Die experimentelle Hypertonie an der Ratte kann durch prophylaktische Selengabe wesentlich reduziert werden. Interessant ist in diesem Zusammenhang die protektive Selenwirkung bei der Kryokonservierung von Herzmuskelfragmenten. Die zur Untersuchung der protektiven Wirkung von Selen und Vitamin E gegenüber Krebs initiierte „SELECT“-Studie („Selenium and Vitamin E Cancer Prevention Trial“) wurde 2008 vor dem geplanten Ende abgebrochen, da ein Nutzen zu dem Zeitpunkt bereits ausgeschlossen werden konnte. Verschiedene randomisierte kontrollierte Studien konnten mit hoher Evidenz keine positive Wirkung der Gabe von Selenpräparaten auf die Verringerung des Krebsrisikos zeigen.
Sources: de.wikipedia.org
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.
United States approval for type 2 diabetes was granted in 2022, and a chronic weight management indication was added later. Approval timelines differ across other jurisdictions. Earlier human data came from phase 1 and phase 2 trials published before those decisions.
Native hormones are short-lived peptides that enzymes degrade within minutes. Tirzepatide carries non-natural residues and a fatty acid chain that resist this breakdown and extend circulation time. The result is a longer interval between administrations than the natural hormones could support.
The peptide backbone and its fatty acid side chain are susceptible to degradation at elevated temperatures. Refrigeration slows hydrolysis, oxidation, and aggregation processes. Labeled storage ranges reflect stability data generated under defined conditions.